YONGLU WANG1,2,*, WEI YOU1, XUEMING LI3,4,*
BIOCELL, Vol.44, No.2, pp. 167-174, 2020, DOI:10.32604/biocell.2020.09023
- 27 May 2020
Abstract Melanoma is the deadliest type of skin cancer and which has a high ability of metastasis. Surgery is an effective
method to treat I or II stage melanoma patients. However, there are few treatment options for metastatic melanoma. Gene
therapy is one of the attractive options and is considered as the future direction for treating melanoma. This review
mainly discusses the properties and challenges of the various gene therapies in melanoma, especially the delivery
systems and gene targeting. More >
Login
Register
